Acer Therapeutics Inc. Annual Depreciation in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Acer Therapeutics Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2022.
  • Acer Therapeutics Inc. Depreciation for the quarter ending March 31, 2023 was $15.5K, a 24.6% decline year-over-year.
  • Acer Therapeutics Inc. annual Depreciation for 2022 was $66K, a 6.88% decline from 2021.
  • Acer Therapeutics Inc. annual Depreciation for 2021 was $70.9K, a 0.14% increase from 2020.
  • Acer Therapeutics Inc. annual Depreciation for 2020 was $70.8K, a 21.5% increase from 2019.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $66K -$4.88K -6.88% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $70.9K +$99.00 +0.14% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $70.8K +$12.5K +21.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $58.3K +$30.5K +110% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $27.7K +$23.7K +594% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-18
2017 $4K +$465 +13.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $3.53K -$348K -99% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 $351K -$36.4K -9.38% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-28
2014 $388K +$52.2K +15.5% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $336K +$31.9K +10.5% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-23
2012 $304K +$93.4K +44.4% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-27
2011 $210K Jan 1, 2011 Dec 31, 2011 10-K 2013-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.